Incident IQ Partners with Level Access to Enhance Digital Accessibility
May 30, 2024 07:02 ET
|
Incident IQ
Atlanta, GA, May 30, 2024 (GLOBE NEWSWIRE) -- Incident IQ, a leader in workflow management solutions for K-12 school districts, has partnered with Level Access, the leading digital accessibility...
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
May 30, 2024 07:00 ET
|
Elevar Therapeutics
Phase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment for uHCCFinal analysis...
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
May 30, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
Notification on transactions concluded by a person associated to a management body of Grigeo Group AB
May 30, 2024 07:00 ET
|
Grigeo Group AB
Grigeo Group AB has received notifications on transactions in issuer's securities concluded by a legal entity associated to a management body of Grigeo Group AB (see attachments). Tomas...
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Within 200m of Reserve Pit and Confirms Continuity of Zone X22 Mineralization to Depth of 550m
May 30, 2024 07:00 ET
|
Troilus Gold Corp.
MONTREAL, Quebec, May 30, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the discovery of a new gold zone named...
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
May 30, 2024 07:00 ET
|
BiomX
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and...
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
May 30, 2024 07:00 ET
|
Lantronix, Inc.
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
May 30, 2024 07:00 ET
|
PMV Pharmaceuticals, Inc.
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
Amplify ETFs Declares May Income Distributions for its ETFs
May 30, 2024 07:00 ET
|
Amplify ETFs
Amplify ETFs announces May income distributions for its ETFs.
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
May 30, 2024 07:00 ET
|
BTG Specialty Pharmaceuticals
Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its new Chief Executive Officer (CEO) effective...
- May 30, 2024 06:39 ET Asia-Pacific Genomic Cancer Panel and Profiling Market Research 2023-2024 & 2033: Advancements in Genomic Research and Increasing Focus on Precision Medicine Within Oncology
- May 30, 2024 06:34 ET World Dural Adhesive Agent for Surgical Market Research 2024-2034: Advancements In Surgical Technologies & Increasing Demand for Single-Use Disposable Medical Products